Safety and Tolerability of Neoadjuvant Radiotherapy Combined With Anti-PD-1 Antibody Toripalimab for Locally Advanced, Resectable Esophageal Squamous Cell Cancer: A Prospective Phase IB Trial

被引：0
|
作者：
Sun, H. [1 ]
Yang, W. [1 ]
Luo, J. [1 ]
Lin, H. [1 ]
Zhou, T. [2 ]
Gong, H. [3 ]
Zhao, D. [1 ]
Niu, Z. [1 ]
Liu, B. [1 ]
Wang, Z. [4 ]
Li, B. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[2] Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
[3] Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[4] Shandong Canc Hosp, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1014
引用
收藏
页码：S102 / S103
页数：2
相关论文
共 50 条
  • [1] Safety And Tolerability Of Neoadjuvant Chemoradiotherapy Combined With Pembrolizumab For Local Advanced, Resectable Esophageal Cancer: Preliminary Results Of A Prospective Phase IB Trial
    Qi, W. X.
    Zhao, S.
    Li, H.
    Chen, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E576 - E577
  • [2] The efficacy and safety of anti-PD-1 antibody toripalimab combined with surufatinib in neoadjuvant treatment of locally advanced thyroid cancer: A phase II study.
    Chen, Jiaying
    Ji, Qinghai
    Wang, Yu
    Huang, Naisi
    Hu, Jiaqian
    Wei, Wenjun
    Huang, Caiping
    Shen, Qiang
    Li, Duanshu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer
    Ma, Ji
    Yao, Nan
    Lu, Jiaying
    Qu, Wanxi
    Cui, Li
    Yuan, Shiwang
    Li, Na
    Tong, Shaodong
    Qin, Zhaohui
    Yao, Yuanhu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma
    Wu, N.
    Li, M.
    Zheng, H.
    Gao, M.
    Wang, D.
    Tian, H.
    Si, L.
    Chen, X.
    Chi, Z.
    Lai, Y.
    Sun, T.
    Zhang, Q.
    Long, G. V.
    Guo, J.
    Cui, C.
    ANNALS OF ONCOLOGY, 2024, 35 (02) : 211 - 220
  • [5] Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer
    Xu, Xin
    Sun, Zhiyong
    Liu, Qiang
    Zhang, Yao
    Shen, Lei
    Zhang, Chenpeng
    Lin, Haiping
    Hu, Bin
    Rong, Ling
    Chen, Haiyan
    Wang, Xiaohang
    Zhao, Xiaojing
    Bai, Yong-Rui
    Ye, Qing
    Ma, Xiumei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (03)
  • [6] The sequence of chemotherapy and anti-PD-1 antibody influence the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell cancer: A phase II study.
    Zhao, Lingdi
    Xing, Wenqun
    Yang, Yonghao
    Zhang, Yong
    Ma, Baozhen
    Fu, Xiaomin
    Liang, Guanghui
    Shang, Yiman
    Wang, Zibing
    Lin, Hongwei
    Gao, Quanli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial
    Jiang, Ning
    Zhang, Jingyuan
    Guo, Zhen
    Wu, Yinan
    Zhao, Lijun
    Kong, Cheng
    Song, Xue
    Gu, Lingling
    Zhao, Yang
    Li, Si
    He, Xia
    Ren, Binhui
    Zhu, Xiangzhi
    Jiang, Ming
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [8] Real-world retrospective study of anti-PD-1 antibody in combination with chemotherapy as a neoadjuvant treatment strategy for locally advanced resectable esophageal squamous cell carcinoma
    Liu, Can
    Yu, Yi
    Shao, Yuanyuan
    He, Lintao
    Wu, Tao
    Zheng, Jinxiu
    Chen, Jun
    Li, Junhe
    JOURNAL OF THORACIC DISEASE, 2024, 16 (07)
  • [9] The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
    Chen, Jia-ying
    Huang, Nai-si
    Wei, Wen-jun
    Hu, Jia-qian
    Cao, Yi-ming
    Shen, Qiang
    Lu, Zhong-wu
    Wang, Yu-long
    Wang, Yu
    Ji, Qing-hai
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7172 - 7180
  • [10] The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
    Jia-ying Chen
    Nai-si Huang
    Wen-jun Wei
    Jia-qian Hu
    Yi-ming Cao
    Qiang Shen
    Zhong-wu Lu
    Yu-long Wang
    Yu Wang
    Qing-hai Ji
    Annals of Surgical Oncology, 2023, 30 : 7172 - 7180
12345